ILYSA BARTOL: Open Payments
NPI 1447820097 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 31 payments from 12 companies in 2025. Trend: 2023 $713 · 2024 $958 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $266 |
| ABBVIE INC. | 4 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| Astellas Pharma US Inc | 3 | $61 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| PFIZER INC. | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
Products named: Wegovy, VRAYLAR, Veozah, VOQUEZNA, GEMTESA, AIRSUPRA, ELIQUIS, INSPIRE.
Industry payments across TN — which companies pay providers there.
